CD44 is involved in the tumor cell invasion and migration in liver cancer.[22] To investigate the proportion of CD44+ cells, we performed the IHC in the primary tumor tissues and identified that CD44+ cells were significantly enriched in HCC272 (Figure S1, Supporting Information), implicating a potential role of CD44+ cells in developing drug resistance. The gene discussed is CD44; the disease is neoplasm.